SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-06-002479
Filing Date
2006-08-16
Accepted
2006-08-16 15:51:03
Documents
10
Period of Report
2006-05-31

Document Format Files

Seq Description Document Type Size
1 REPORT FOR THE FISCAL YEAR ENDED: MAY 31, 2006 form20f.htm 20-F 736577
2 AMENDMENT TO EMPLOYMENT AGREEMENT DATED OCTOBER 1, 2005 exhibit4s.htm EX-4.S 4550
3 AMENDMENT TO DEVELOPMENT AGREEMENT DATED JULY 2, 2004 exhibit4t.htm EX-4.T 5160
4 AMENDMENT TO DEVELOPMENT AGREEMENT DATED JUNE 1, 2000 exhibit4u.htm EX-4.U 5380
5 AMENDED STOCK OPTION PLAN APPROVED OCTOBER 25, 2005 exhibit4v.htm EX-4.V 31252
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 exhibit12-1.htm EX-12.1 5557
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 exhibit12-2.htm EX-12.2 5541
8 CERTIFICATION OF CFO & CFO PURSUANT TO SECTION 906 exhibit13-1.htm EX-13.1 3481
9 friesensig.gif GRAPHIC 1304
10 orgchart.gif GRAPHIC 3807
  Complete submission text file 0001062993-06-002479.txt   806175
Mailing Address SUITE 4 1200 WAVERLY STREET WINNIPEG A2 R3T 0P4
Business Address SUITE 4 1200 WAVERLY STREET WINNIPEG A2 R3T 0P4 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-31995 | Film No.: 061038296
SIC: 2834 Pharmaceutical Preparations